• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 233/56 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Patent holdings for IPC class C07D 233/56

Total number of patents in this class: 208

10-year publication summary

22
23
26
8
10
8
12
6
4
6
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2220
12
BASF SE
21303
8
FUJIFILM Corporation
30512
7
Agency for Science, Technology and Research
3729
5
University of Maryland, Baltimore
1066
5
Bayer Cropscience AG
1846
4
Nippon Soda Co., Ltd.
885
4
sanofi-aventis
302
4
Janssen Pharmaceutica N.V.
3171
3
Alexion Pharmaceuticals, Inc.
648
3
NMD Pharma A/S
48
3
Novartis AG
10263
2
Merck Patent GmbH
5725
2
Centre National de La Recherche Scientifique
11016
2
Murata Manufacturing Co., Ltd.
25722
2
Dow Technology Investments LLC
279
2
PRC-DeSoto International, Inc.
568
2
University of Florida Research Foundation, Inc.
4173
2
BioLab Sanus Farmaceutica Ltda.
46
2
The Board of Trustees of the University of Alabama
432
2
Other owners 132